Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experienceD O Dixon, B Neilan, S E Jones, et al.Investigational New Drugs|January 1, 1986
Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanomaT A Braich, S E Salmon, A Robertone, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphomaA T Stopeck, A Gessner, T P Miller, et al.Journal of Dairy Science|September 1, 1992
Influence of dietary fiber and buffer value index on the ruminal milieu of lactating dairy cowsP Le Ruyet, W B Tucker, J F Hogue, et al.American Journal of Clinical Oncology|June 1, 1991
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group StudyD D Von Hoff, S Green, D S Alberts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsetsC P Leith, C M Spier, T M Grogan, et al.Journal of the National Cancer Institute|January 16, 1991
Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administrationG D Pennock, W S Dalton, W R Roeske, et al.Cancer|December 1, 1990
Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease. A Southwest Oncology Group studyC M Mansfield, C Fabian, S Jones, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2013
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213S H Bernstein, E Epner, J M Unger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot studyC W Taylor, J Crowley, S K Williamson, et al.Pageof 11